West Pharmaceutical Services, Inc. (WST)

WST Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	853.9	894.3	762.6	615.5	439.1
Cash & Cash Equivalents	853.9	894.3	762.6	615.5	439.1
Cash Growth	-4.52%	17.27%	23.90%	40.17%	30.14%
Receivables	512	507.4	489	385.3	319.3
Inventory	434.7	414.8	378.4	321.3	235.7
Other Current Assets	135.8	103	112	51.6	64.6
Total Current Assets	1,936	1,920	1,742	1,374	1,059
Property, Plant & Equipment	1,513	1,263	1,127	1,012	909.4
Long-Term Investments	210	204.9	207.7	214.7	192.7
Goodwill and Intangibles	123.6	125.7	132.9	141.6	137.6
Other Long-Term Assets	47	104	104.4	52.3	43
Total Long-Term Assets	1,893	1,697	1,572	1,420	1,283
Total Assets	3,830	3,617	3,314	2,794	2,341
Accounts Payable	242.4	215.4	232.2	213.1	156.8
Current Debt	151.7	18.2	53.5	12.4	11.9
Other Current Liabilities	277.7	285.4	308.4	277.9	172.9
Total Current Liabilities	671.8	519	594.1	503.4	341.6
Long-Term Debt	157.3	299.7	271.8	313.3	317.4
Other Long-Term Liabilities	119.4	113.2	112.5	122.6	109.2
Total Long-Term Liabilities	276.7	412.9	384.3	435.9	426.6
Total Liabilities	948.5	931.9	978.4	939.3	768.2
Total Debt	309	317.9	325.3	325.7	329.3
Debt Growth	-2.80%	-2.27%	-0.12%	-1.09%	67.92%
Retained Earnings	3,523	2,988	2,457	1,847	1,549
Comprehensive Income	-143.8	-183	-159.6	-110.6	-149.6
Shareholders' Equity	2,881	2,685	2,335	1,855	1,573
Net Cash / Debt	544.9	576.4	437.3	289.8	109.8
Net Cash / Debt Growth	-5.46%	31.81%	50.90%	163.93%	-22.29%
Net Cash Per Share	7.24	7.60	5.73	3.82	1.46
Working Capital	1,265	1,401	1,148	870.3	717.1
Book Value Per Share	38.77	36.09	31.39	25.09	21.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).